On 06th Mar 2015, the U.S. Food and Drug Administration approved Isavuconazonium sulfate (Cresemba), a new antifungal drug. Isavuconazonium sulfate can be used to treat adults (18 years and above) with… Invasive Aspergillosis (IA) Invasive Mucormycosis (IM) Most common side effects of Isavuconazonium sulfate include Nausea, Vomiting, Diarrhea, Headache, Abnormal liver blood tests, Low potassium levels in the blood (hypokalemia), Constipation, Shortness of breath (dyspnea), Coughing and Tissue swelling (peripheral edema). And the serious side effects include Liver problems, Infusion reactions and severe allergic and skin reactions.
Isavuconazonium sulfate is contraindicatedin… Persons with known hypersensitivity to Isavuconazole. Coadministration of strong CYP3A4 inhibitors (Ketoconazole or high-dose Ritonavir). Coadministration of strong CYP3A4 inducers (Rifampin, carbamazepine, St.…
